DrugCards

02/06/2026

🧐𝘼 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙧𝙚𝙥𝙤𝙧𝙩𝙨 𝙖 𝙨𝙞𝙙𝙚 𝙚𝙛𝙛𝙚𝙘𝙩. 𝙒𝙝𝙚𝙧𝙚 𝙙𝙤 𝙮𝙤𝙪 𝙘𝙝𝙚𝙘𝙠 𝙞𝙛 𝙨𝙞𝙢𝙞𝙡𝙖𝙧 𝙘𝙖𝙨𝙚𝙨 𝙝𝙖𝙫𝙚 𝙗𝙚𝙚𝙣 𝙧𝙚𝙥𝙤𝙧𝙩𝙚𝙙 𝙬𝙤𝙧𝙡𝙙𝙬𝙞𝙙𝙚?
From 🌍WHO's VigiAccess to 🇺🇸FDA AEMS and 🇪🇺EudraVigilance, public pharmacovigilance databases contain millions of real-world safety reports - but each comes with important limitations.
🧩We've put together a practical guide to the key databases every drug safety professional should know.

👉Read the new DrugCard article: https://drug-card.io/blog/public-pharmacovigilance-databases-for-drug-side-effects/

01/06/2026

🎉 DrugCard — 5 years!

What started as a team of 3 passionate people has grown into a team of 30 amazing professionals.

This year brought exciting milestones, new opportunities, and even our first acquisition. But today, we’re celebrating something even more important — the people behind DrugCard.

Thank you to our team, customers, and partners for being part of this journey 🧡

We had an incredible time celebrating together, and we’re excited for everything that comes next.

The first 5 years were amazing. The best is yet to come. 🚀

21/05/2026

We’re proud to share that DrugCard is now an official member of EUCROF (European CRO Federation). 🚀

Joining EUCROF is an important step for our team and reflects our ongoing commitment to supporting the global clinical research and pharmacovigilance community with innovative, practical, and transparent solutions.

At DrugCard, we believe that the future of drug safety and clinical research depends on stronger collaboration, responsible innovation, and the thoughtful use of technology, especially AI and automation.

Looking forward to new collaborations, knowledge sharing, and contributing to the conversations that move our industry forward.

19/05/2026

🥪𝗪𝗵𝗮𝘁 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗘𝗮𝘁 𝗮𝗻𝗱 𝗗𝗿𝗶𝗻𝗸 𝗖𝗼𝘂𝗹𝗱 𝗕𝗲 𝗖𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗦𝗮𝗳𝗲𝘁𝘆
Most people think drug 💊safety is only about the medication itself.
But what about the meal taken with it?
🥗Food can significantly change how medications work - increasing toxicity, reducing effectiveness, and contributing to preventable adverse events.

From 🧃grapefruit juice-CYP-mediated interactions to dairy products that reduce the absorption of certain antibiotics, our new blog explores why drug–food interactions remain an underrecognized challenge in real-world pharmacovigilance: https://drug-card.io/blog/how-food-and-drug-interactions-affect-drug-safety/

18/05/2026

🚀 We’re hosting a webinar you don’t want to miss.
Shaping the Future of Pharmacovigilance: Leadership, Communication & Community

📅 June 4, 2026 · 13:00 CEST · Online · Free

Pharmacovigilance is evolving fast - and the professionals leading that change aren’t just technical experts. They’re community builders, communicators, and strategic thinkers.

This webinar brings together two of them.

We’re sitting down with Julia Appelskog, Head of QPPV Office at CSL and an expert in PV & AI Innovation, and Artem Horilyk a pharmacovigilance and AI automation expert at DrugCard, for an open, honest conversation about what it actually takes to lead in this field.

What we’ll cover:
✅ Career paths from entry-level to global leadership
✅ Building and scaling professional communities
✅ Translating global PV initiatives into local impact
✅ What makes conferences and events truly valuable
✅ The future of PV - AI, automation, and the human expertise that still matters most

Whether you’re early in your PV career or already leading teams - this one’s for you.

🎟️ Participation is free. Registration is required.

18/05/2026

🚀 We're hosting a webinar you don't want to miss.
Shaping the Future of Pharmacovigilance: Leadership, Communication & Community

📅 June 4, 2026 · 13:00 CEST · Online · Free · English

Pharmacovigilance is evolving fast - and the professionals leading that change aren't just technical experts. They're community builders, communicators, and strategic thinkers.

This webinar brings together two of them.

We're sitting down with Julia Appelskog, Head of QPPV Office at CSL and an expert in PV & AI Innovation, and Артем Горілик a pharmacovigilance and AI automation expert at DrugCard, for an open, honest conversation about what it actually takes to lead in this field.

What we'll cover:
✅ Career paths from entry-level to global leadership
✅ Building and scaling professional communities
✅ Translating global PV initiatives into local impact
✅ What makes conferences and events truly valuable
✅ The future of PV - AI, automation, and the human expertise that still matters most

Whether you're early in your PV career or already leading teams - this one's for you.

🎟️ Participation is free. Registration is required. 👉 https://drug-card-26507628.hs-sites-eu1.com/shaping-the-future-of-pv?utm_source=facebook&utm_medium=organic_social&utm_campaign=shaping_future_of_pv_webinar&utm_content=facebook_page

12/05/2026

🎥 The 2nd Kyiv Drug Safety Day vlog is here!

We’ve finally finished it — a bit of behind-the-scenes, a bit of атмосфера, and a bit of you 🙂

👉 https://www.youtube.com/watch?v=UsAeh8LdDCc

Watch it to relive the day (and maybe spot yourself on camera 👀)

And one more thing: if you enjoyed the conference, we regularly share insights, materials, and updates in our socials:

▶️ YouTube - https://www.youtube.com/
💼 LinkedIn - linkedin.com/company/drugcards
📘 Facebook - facebook.com/drugcards
📸 Instagram - https://www.instagram.com/drug.card/

Feel free to follow — there’s more coming 💙

Join us behind the scenes of Kyiv Drug Safety Day 2 — Ukraine's community conference where pharmacovigilance professionals, regulators, academics, and indust...

05/05/2026

𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗘𝘃𝗲𝗿𝘆𝗱𝗮𝘆 𝗡𝗮𝘀𝗮𝗹 𝗗𝗲𝗰𝗼𝗻𝗴𝗲𝘀𝘁𝗮𝗻𝘁𝘀
Nasal decongestants 🤧are used by millions every day for quick relief. But what happens when “just a spray” turns into something much more serious?
A recent case 📑describes a young, healthy patient who developed cardiac arrest after excessive use of a common nasal spray. Around the same time, 🇬🇧UK regulators introduced stricter limits on the duration these products could be used. Coincidence? Not really.

💡In our latest blog, we explore a real-world safety case, updated regulatory recommendations, and what this means for patient safety in everyday practice.
👉Read more here: https://drug-card.io/blog/nasal-decongestants-and-the-price-of-quick-relief/